Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers

Clinical Cancer Research

Volumn 3, Issue 7, 1997, Pages 1051-1058

  Nishio, Masayuki ^a   Koshikawa, Takashi ^a   Yatabe, Yasushi ^a   Kuroishi, Tetsuo ^a   Suyama, Motokazu ^a   Nagatake, Masaaki ^a   Sugiura, Takahiko ^a   Ariyoshi, Yutaka ^a   Mitsudomi, Tetsuya ^a   Takahashi, Toshitada ^a   Takahashi, Takashi ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; FEMALE; FOLLOW UP; GENE EXPRESSION REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG BIOPSY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; TUMOR BIOPSY; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CYCLIN D1; FEMALE; GENES, P53; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETINOBLASTOMA PROTEIN; SMOKING; SURVIVAL ANALYSIS;

EID: 0030794029     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Statistics and Information Department, Vital Statistics 1994 Japan, Vol. 3, pp. 96-108. Tokyo: Ministry of Health and Welfare, 1996.
2. Kuroishi, T., Hirose, K., Tominaga, S., Ogawa, H., and Tajima, K. Prediction of future cancer mortality in Japan. Jpn. J. Clin. Oncol., 22: 365-369, 1992.
3. Minna, J. D., Pass, H., Glatstein, E., and Ihde, D. C. Lung Cancer. In: V. T. DeVita, S. Rosenberg, and S. Hellman (eds.), Principles and Practice of Oncology, pp. 591-705. Philadelphia: J. B. Lippincott Co., 1989.
4. Takahashi, T., Nau, M. M., Chiba, I., Birrer, M. J., Rosenberg, R. K., Vinocour, M., Levitt, M., Pass, H., Gazdar, A. F., and Minna, J. D. p53: a frequent target for genetic abnormalities in lung cancer. Science (Washington DC), 246: 491-494, 1989.
5. Harbour, J. W., Lai, S-L., Whang-Peng, J., Gazdar, A. F., Minna, J. D., and Kaye, F. J. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science (Washington DC), 241: 353-357, 1988.
6. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., III, Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436-440, 1994.
7. Washimi, O., Nagatake, M., Osada, H., Ueda, R., Koshikawa, T., Seki, T., Takahashi, T., and Takahashi, T. In vivo occurrence of p16 (MTS1) and p15 (MTS2) alterations preferentially in non-small cell lung cancers. Cancer Res., 55: 514-517, 1995.
8. Rodenhuis S., van de Wetering, M., Mooi, W., Evers, S. G., van Zandwijk, N., and Bos, J. L. Mutational activation of the K-ras oncogene: a possible pathogenetic factor in adenocarcinoma of the lung. N. Engl. J. Med., 317: 929-935, 1987.
9. Little, C., Nau, M., Carney, D., Gazdar, A. F., and Minna, J. D. Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature (London), 306: 194-196, 1983.
10. Nau, M., Brooks, B., Battey, J,. Sausville, E., Gazdar, A. F., Kirsch, I. R., McBride, O. W., Bertness, V., Hollis, G. F., and Minna, J. D. L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer. Nature (London), 318: 69-73, 1985.
11. Naylor, S., Johnson, B., Minna, J., and Sakaguchi, A. Y. Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer. Nature (London), 329: 451-454, 1987.
12. Hibi, K., Takahashi, T., Yamakawa, K., Ueda, R., Sekido, Y., Ariyoshi, Y., Suyama, M., Takagi, H., Nakamura, Y., and Takahashi, T. Three distinct regions involved in 3p deletion in human lung cancer. Oncogene, 7: 445-449, 1992.
13. Shiraishi, M., Morinaga, S., Noguchi, M., Shimosato, Y., and Sekiya, T. Loss of genes on the short arm of chromosome 11 in human lung carcinomas. Jpn. J. Cancer Res., 78: 1302-1308, 1987.
14. Shiseki, M., Kohno, T., Nishikawa, R., Sameshima, Y., Mizoguchi, H., and Yokota, J. Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma. Cancer Res., 54: 5643-5648, 1994.
15. Nagatake, M., Osada, H., Kondo, M., Uchida, K., Nishio, M., Shimokata, K., Takahashi, T., and Takahashi, T. Aberrant hypermethylation at the bcl-2 locus at 18q21 in human lung cancers. Cancer Res., 56: 1886-1891, 1996.
16. Johnson, B. E., Ihde, D. C., Makuch, R. W., Gazdar, A. F., Carney, D. N., Oie, H., Russell, E., Nau, M. M., and Minna, J. D. myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course. J. Clin. Invest., 79: 1629-1634, 1987.
17. Slebos, R. J. C., Kibbelaar, R. E., Dalesio, O., Kooistra, A., Stam, J., Meijer, C. J. L. M., Wagenaar, S. S., Vanderschueren, R. G. J. R. A., van Zandwijik, N., Mooi, W. J., Bos, J. L., and Rodenhuis, S. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N. Engl. J. Med., 323: 561-565, 1990.
18. Mitsudomi, T., Steinberg, S. M., Oie, H. K., Mulshine, J. L., Phelps, R., Viallet, J., Pass, H., Minna, J. D., and Gazdar, A. F. ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent. Cancer Res., 57: 4999-5002, 1991.
19. Quinlan, D. C., Davidson, A. G., Summers, C. L., Warden, H. E., and Doshi, H. M. Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res., 52: 4828-4831, 1992.
20. Horio, Y., Takahashi, T., Kuroishi, T., Hibi, K., Suyama, M., Niimi, T., Shimokata, K., Yamakawa, K., Nakamura, Y., Ueda, R., and Takahashi, T. Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell cancer. Cancer Res., 53: 1-4, 1993.
21. Mitsudomi, T., Oyama, T., Kusano, T., Osaki, T., Nakanishi, R., and Shirakusa, T. Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer. J. Natl. Cancer Inst., 85: 2018-2023, 1993.
22. Pezzela, F., Turley, H., Kuzu, I., Tungekar, M. F., Dunnill, M. S., Pierce, C. B., Harris, A., Gatter, K. C., and Mason, D. Y. bcl-2 protein in non-small-cell lung carcinoma. N. Engl. J. Med., 329: 690-694, 1993.
23. Xu, H. J., Quinlan, D. C., Davidson, A. G. H., Hu, S. X., Summers, C. L., Li, J., and Benedict, W. F. Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma. J. Natl. Cancer Inst., 86: 695-699, 1994.
24. Kern, J. A., Slebos, R. J., Top, B., Rodenhuis, S., Lager, D., Robinson, R. A., Weiner, D., and Schwartz, D. A. c-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas. J. Clin. Invest., 93: 516-520, 1994.
25. Lee, J. S., Yoon, A., Kalapurakal, S. K., Ro, J. Y., Lee, J., Tu, N., Hittelman, W. N., and Hong, W. K. Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor. J. Clin. Oncol., 13: 1893-1903, 1995.
26. Nishio, M., Koshikawa, T., Kuroishi, T., Suyama, M., Uchida, K., Takagi, Y., Washimi, O., Sugiura, T., Ariyoshi, Y., Takahashi, T., Ueda, R., and Takahashi, T. Prognostic significance of abnormal p53 accumulations in primary, resected non-small-cell lung cancers. J. Clin. Oncol., 14: 497-502, 1996.
27. WHO. WHO Histological Typing of Lung Tumors, Ed. 2, pp. 15-32. Geneva: WHO, 1981.
28. Mountain, C. F. A new international staging system for lung cancer. Chest, 89: 225s-233s, 1986.
29. Bennett, W. P., Colby, T. V., Travis, W. D., Borkowski, A., Jones, R. T., Lane, D. P., Metcalf, R. A., Samet, J. M., Takeshima, Y., Gu, J. R., Vähäkangas, K. H., Soini, Y., Pääkkö, P., Welsh, J. A., Trump, B. F., and Harris, C. C. p53 protein accumulates frequently in early bronchial neoplasia. Cancer Res., 53: 4817-4822, 1993.
30. Shimosato, Y., Noguchi, M., and Matsuno, Y. Adenocarcinoma of the lung: its development and malignant progression. Lung Cancer, 9: 99-108, 1993.
31. Weston, A., Willey, J., Modali, R., Sugimura, H., McDowell, E. M., Resau, J., Light, B., Haugen, A., Mann, D. L., Trump, B. F., and Harris, C. C. Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung. Proc. Natl. Acad. Sci. USA, 86: 5099-5103, 1989.
32. Chiba, I., Takahashi, T., Nau, M., D'Amico, D., Curiel, D. T., Mitsudomi, T., Buchhagen, D. L., Carbone, D., Piantadosi, S., Koga, H., Reissmann, P. T., Slamon, D. J., Holmes, E. C., and Minna, J. D. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene, 5: 1603-1610, 1990.
33. Tsuchiya, E., Nakamura, Y., Weng, S-Y., Nakagawa. K., Tsuchiya, S., Sugano, H., and Kitagawa, T. Allelotype of non-small cell lung carcinoma: comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. Cancer Res., 52: 1478-1481, 1992.
34. Motokura, T., and Arnold, A. Cyclins and oncogenesis. Biochim. Biophys. Acta, 1155: 63-78, 1993.
35. Jiang, W., Kahn, S. M., Zhou, P., Zhang, Y., Cacace, A. M., Infante, A. S., Doi, S., Santella, R. M., and Weinstein, I. B. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene, 8: 3447-3457, 1993.
36. 1 phase in rodent fibroblasts. Genes Dev., 7: 1559-1571, 1993.
37. Pagano, M., Theodora, A. M., Tam, S. W., and Draetta, G. F. Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. Genes Dev., 8: 1627-1639, 1994.
38. Han, E. K-H., Sgambat, A., Jiang, W., Zhang, Y-J., Santella, R., Doki, Y., Cacace, A. M., Schieren, I., and Weinstein, I. B. Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth. Oncogene, 10: 953-961, 1995.
39. Chen, X., Bargonetti, J., and Prives, C. p53. through p21 (WAF1/ CIP1), induces cyclin D1 synthesis. Cancer Res., 55: 4257-4263, 1995.
40. Del Sal, G., Murphy, M., Ruaro, E. M., Lazarevic, D., and Levine, A. Cyclin D1 and p21/waf1 are both involved in p53 growth suppression. Oncogene, 12: 177-185, 1996.
41. Marhin, W. W., Hei, Y-J., Chen, S., Jiang, Z., Gallic, B. L., Phillips, R. A., and Penn, L. Z. Loss of Rb and Myc activation co-operate to suppress cyclin D1 and contribute to transformation. Oncogene, 12: 43-52, 1996.
42. Freeman, R. S., Estus, S., and Johnson, E. M., Jr. Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of cyclin D1 during programmed cell death. Neuron, 12: 343-355, 1994.
43. Berenson, J. R., Koga, H., Yang, J., Pearl, J., Holmes, E. C., and Figlin, R. Frequent amplification of the bcl-1 locus in poorly differentiated squamous cell carcinoma of the lung. Oncogene, 5: 1343-1348, 1990.
44. 1. J. Cell Biol., 125: 625-638, 1994.
45. Müller, H., Lukas, J., Schneider, A., Warthoe, P., Bartek, J., Eilers, M., and Strauss, M. Cyclin D1 expression is regulated by the retinoblastoma protein. Proc. Natl. Acad. Sci. USA. 91: 2945-2949, 1994.
46. Spitkovsky, D., Steiner, P., Gopalkrishnan, R. V., Eilers, M., and Jansen-Durr, P. The role of p53 in coordinated regulation of cyclin D1 and p21 gene expression by the adenovirus E1A and E1B oncogenes. Oncogene, 10: 2421-2425, 1995.